Biosimilars in Rheumatoid Arthritis: Wave of the Future?Biosimilars in Rheumatoid Arthritis: Wave of the Future?

The biosimilars of etanercept and infliximab are equivalent to their respective reference biologics, new research shows, but the jury is still out on how big an impact biosimilars will have. Medscape Medical News

Source: Medscape Medical News Headlines - June 13, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news